These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 35133529)

  • 1. Understanding PrEP Acceptability Among Priority Populations: Results from a Qualitative Study of Potential Users in Central Uganda.
    Sundararajan R; Wyatt MA; Muwonge TR; Pisarski EE; Mujugira A; Haberer JE; Ware NC
    AIDS Behav; 2022 Aug; 26(8):2676-2685. PubMed ID: 35133529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing acceptability of pre-exposure prophylaxis (PrEP) among participants in an HIV vaccine preparedness study in southwestern Uganda.
    Nakamanya S; Kawuma R; Kibuuka D; Kusemererwa S; McCormack S; Ruzagira E; Seeley J;
    PLoS One; 2022; 17(7):e0271104. PubMed ID: 35905052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding Demand for PrEP and Early Experiences of PrEP Use Among Young Adults in Rural Kenya and Uganda: A Qualitative Study.
    Camlin CS; Koss CA; Getahun M; Owino L; Itiakorit H; Akatukwasa C; Maeri I; Bakanoma R; Onyango A; Atwine F; Ayieko J; Kabami J; Mwangwa F; Atukunda M; Owaraganise A; Kwarisiima D; Sang N; Bukusi EA; Kamya MR; Petersen ML; Cohen CR; Charlebois ED; Havlir DV
    AIDS Behav; 2020 Jul; 24(7):2149-2162. PubMed ID: 31955361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake of and adherence to oral pre-exposure prophylaxis among adolescent girls and young women at high risk of HIV-infection in Kampala, Uganda: A qualitative study of experiences, facilitators and barriers.
    Kayesu I; Mayanja Y; Nakirijja C; Machira YW; Price M; Seeley J; Siu G
    BMC Womens Health; 2022 Nov; 22(1):440. PubMed ID: 36357920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of HIV-related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: a qualitative study.
    Velloza J; Khoza N; Scorgie F; Chitukuta M; Mutero P; Mutiti K; Mangxilana N; Nobula L; Bulterys MA; Atujuna M; Hosek S; Heffron R; Bekker LG; Mgodi N; Chirenje M; Celum C; Delany-Moretlwe S;
    J Int AIDS Soc; 2020 Mar; 23(3):e25463. PubMed ID: 32144874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qualitative Assessment of Barriers and Facilitators of PrEP Use Before and After Rollout of a PrEP Program for Priority Populations in South-central Uganda.
    Ddaaki W; Strömdahl S; Yeh PT; Rosen JG; Jackson J; Nakyanjo N; Kagaayi J; Kigozi G; Nakigozi G; Grabowski MK; Chang LW; Reynolds SJ; Nalugoda F; Ekström AM; Kennedy CE
    AIDS Behav; 2021 Nov; 25(11):3547-3562. PubMed ID: 34240317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scaling-up PrEP Delivery in Sub-Saharan Africa: What Can We Learn from the Scale-up of ART?
    O'Malley G; Barnabee G; Mugwanya K
    Curr HIV/AIDS Rep; 2019 Apr; 16(2):141-150. PubMed ID: 30796608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adolescent-Centered HIV Prevention: Perspectives on Acceptability of Oral Antiretroviral Pre-exposure Prophylaxis for Adolescents in a Global Priority Setting.
    Giovenco D; Kuo C; Underhill K; Hoare J; Operario D
    Arch Sex Behav; 2021 Oct; 50(7):2921-2931. PubMed ID: 34561792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceptability of HIV Pre-Exposure Prophylaxis Among Transgender Women in India: A Qualitative Investigation.
    Chakrapani V; Shunmugam M; Rawat S; Baruah D; Nelson R; Newman PA
    AIDS Patient Care STDS; 2020 Feb; 34(2):92-98. PubMed ID: 31951490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A qualitative study to explore daily versus on-demand oral pre-exposure prophylaxis (PrEP) in young people from South Africa, Uganda and Zimbabwe.
    Dietrich JJ; Ahmed N; Tshabalala G; Wu M; Mulaudzi M; Hornschuh S; Atujuna M; Muhumuza R; Ssemata AS; Stranix-Chibanda L; Nematadzira T; Bekker LG; Martinson N; Seeley J; Fox J
    PLoS One; 2023; 18(6):e0287627. PubMed ID: 37384792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development of a conceptual framework on PrEP stigma among adolescent girls and young women in sub-Saharan Africa.
    Hartmann M; Nyblade L; Otticha S; Marton T; Agot K; Roberts ST
    J Int AIDS Soc; 2024 Feb; 27(2):e26213. PubMed ID: 38379129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding user perspectives of and preferences for oral PrEP for HIV prevention in the context of intervention scale-up: a synthesis of evidence from sub-Saharan Africa.
    Eakle R; Weatherburn P; Bourne A
    J Int AIDS Soc; 2019 Jul; 22 Suppl 4(Suppl Suppl 4):e25306. PubMed ID: 31328429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined HIV Adolescent Prevention Study (CHAPS): comparison of HIV pre-exposure prophylaxis regimens for adolescents in sub-Saharan Africa-study protocol for a mixed-methods study including a randomised controlled trial.
    Nash S; Dietrich J; Ssemata AS; Herrera C; O'Hagan K; Else L; Chiodi F; Kelly C; Shattock R; Chirenje M; Lebina L; Khoo S; Bekker LG; Weiss HA; Gray C; Stranix-Chibanda L; Kaleebu P; Seeley J; Martinson N; Fox J;
    Trials; 2020 Oct; 21(1):900. PubMed ID: 33121503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Providers' Attitudes and Experiences with Pre-Exposure Prophylaxis Implementation in a Population-Based Study in Kenya and Uganda.
    Camlin CS; Getahun M; Koss CA; Owino L; Akatukwasa C; Itiakorit H; Onyango A; Bakanoma R; Atwine F; Maeri I; Ayieko J; Atukunda M; Owaraganise A; Mwangwa F; Sang N; Kabami J; Kaplan RL; Chamie G; Petersen ML; Cohen CR; Bukusi EA; Kamya MR; Havlir DV; Charlebois ED
    AIDS Patient Care STDS; 2022 Oct; 36(10):396-404. PubMed ID: 36201226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake and retention on HIV pre-exposure prophylaxis among key and priority populations in South-Central Uganda.
    Kagaayi J; Batte J; Nakawooya H; Kigozi B; Nakigozi G; Strömdahl S; Ekström AM; Chang LW; Gray R; Reynolds SJ; Komaketch P; Alamo S; Serwadda D
    J Int AIDS Soc; 2020 Aug; 23(8):e25588. PubMed ID: 32785976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Pre-Exposure Prophylaxis-Stigma Paradox: Learning from Canada's First Wave of PrEP Users.
    Grace D; Jollimore J; MacPherson P; Strang MJP; Tan DHS
    AIDS Patient Care STDS; 2018 Jan; 32(1):24-30. PubMed ID: 29185801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications for PrEP Uptake in Young Adults Experiencing Homelessness: A Mixed Methods Study.
    Santa Maria D; Gallardo KR; Narendorf S; Petering R; Barman-Adhikari A; Flash C; Hsu HT; Shelton J; Ferguson K; Bender K
    AIDS Educ Prev; 2019 Feb; 31(1):63-81. PubMed ID: 30742477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Client experiences with "Dynamic Choice Prevention," a model for flexible patient-centred HIV prevention delivery in rural Eastern Africa.
    Camlin CS; Arunga T; Johnson-Peretz J; Akatukwasa C; Atwine F; Onyango A; Owino L; Kamya MR; Petersen ML; Chamie G; Kakande E; Kabami J; Balzer LB; Havlir DV; Ayieko J
    J Int AIDS Soc; 2024 Jul; 27(7):e26336. PubMed ID: 39020454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A qualitative exploration to understand barriers and facilitators to daily oral PrEP uptake and sustained adherence among HIV-negative women planning for or with pregnancy in rural Southwestern Uganda.
    Atukunda EC; Owembabazi M; Pratt MC; Psaros C; Muyindike W; Chitneni P; Bwana MB; Bangsberg D; Haberer JE; Marrazzo J; Matthews LT
    J Int AIDS Soc; 2022 Mar; 25(3):e25894. PubMed ID: 35324081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding, Contextualizing, and Addressing PrEP Stigma to Enhance PrEP Implementation.
    Calabrese SK
    Curr HIV/AIDS Rep; 2020 Dec; 17(6):579-588. PubMed ID: 32965576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.